血液制剂全程闭环智能路径质量和安全实时控制  

Quality and safety real time control of the whole closed loop intelligent path of blood products

作　　者：吴承高[1] 曹磊[1] 李建林[1] 龚剑国[1] 李劲波 向军 熊伟 范时海 乐爱平[1] 

机构地区：[1]南昌大学第一附属医院,江西南昌330006 [2]江西先锋信息产业有限公司

出　　处：《中国输血杂志》2017年第2期112-116,共5页Chinese Journal of Blood Transfusion

基　　金：江西省科技重大项目(20144BBG70001)

摘　　要：目的通过构建临床用血管理与评价信息系统的血液制剂全程闭环智能路径,以实现血液制剂在临床用血全程质量和安全的实时控制、信息共享及质量持续改进。方法按照临床用血三级组织管理架构,依据医院临床用血管理委员会审定的临床用血质量管理与技术指南,采用智能信息化实时控制手段对血液制剂全程质量和安全实施多部门全员参与,过程与环节控制,质量分析与持续改进。结果 1)针对血液制剂管理要素和技术要素,采用智能信息化实时控制手段,对血液制剂全程的基础、环节、终末质量和安全进行了闭环路径智能实时控制及质量持续改进,涵盖了自体和异体成分血的路径轨迹;2)血液制剂全程闭环路径与临床输血、血液标本、质量分析与持续改进等,全程闭环路径间智能无缝对接,信息共享,具备血液制剂轨迹与患者轨迹交叉融合,智能信息检索与实时共享,全程路径轨迹实时控制,质量持续改进等特点。结论血液制剂全程闭环智能路径,实现了血液制剂在临床用血全程闭环智能路径轨迹化的质量和安全实时控制,有效保障了血液制剂质量与临床输血安全。Objective To achieve quality and safety real-time control,information sharing and quality continuous improvement of blood products in the whole process of clinical blood transfusion,through the construction of a whole closed-loop intelligent path of blood products for clinical blood use management and evaluation information system. Methods According to a tertiary level organizational management structure and clinical blood use quality management and technology guideline which were approved by the hospital clinical blood use management committee,intelligent information real-time control was adopted to implement whole process quality and safety management on blood products with multi-sector participation,procedure and process control,quality analysis and continuous improvement. Results Based on blood product management and technical elements,intelligent information real-time control technology was adopted to manage the whole process of blood products and was able to achieve a closed-loop intelligent path with real-time control and continuous quality improvement for the primary,link and terminal quality and safety of the whole process（ which covers the pathways of allogeneic blood components and autologous blood components）. The closed-loop paths of blood products,the clinical transfusion process,the quality analysis of blood samples and the continuous improvement integrated perfectly with each other through information sharing. The pathway of blood product was integrated with patients＇ transfusion goals due to intelligent information retrieval and real-time sharing. The path can achieve real-time control on the whole process path trajectory,and can actively improve the management of quality. Conclusion The whole process in the closed-loop path of blood products achieves quality and safety in realtime control of the intelligent path trajectory for clinical blood use,and can effectively guarantee the quality of blood products and the safety of clinical blood transfusion.

关 键 词：全程闭环 智能路径 实时控制 质量和安全 血液制剂 

分 类 号：R457.1[医药卫生—治疗学] R197.323[医药卫生—临床医学]